Learning points for clinicians
Hereditary spherocytosis is a rare inherited disease believed to be asymptomatic until haemolytic anaemia symptoms manifest. However, when hyperviscosity is also present, hereditary spherocytosis may be responsible for the occlusion of micro-arteries such as the retinal artery.
Case report
A 23-year-old Japanese woman presented with the sudden onset of a visual disturbance in the left eye. She was travelling domestically in the summer and noticed her vision was impaired at night in the lower half of the nose side of view in the left eye after drinking during the day. An ophthalmologist at her destination diagnosed her with branch retinal artery occlusion (BRAO) of the left eye ( Figure 1A ). Upon returning home, she visited the outpatient clinic of our department to determine what caused her BRAO. Physical examination revealed no remarkable findings except visual disturbance. Laboratory examination revealed red blood cell counts (RBCs), haemoglobin (Hb) and haematocrit (Ht) levels were elevated to 504 Â 10 4 /ll (reference range: 386-492), 15.6 g/dl (11.6-14.8) and 44.7% (35.1-44.4), respectively, compared to the previous year (439 Â 10 4 /ll, 12.9 g/ dl and 39.3%). White blood cell counts and platelets were 5, 200/ ll and 19.2 Â 10 4 /ll, respectively. C-reactive protein was 0.01 mg/ dl. Liver and renal function were normal. Prothrombin time and activated partial thromboplastin time were also normal. Serological testing including ds-DNA antibody, Sm antibody, SSA antibody, RNP antibody, lupus anticoagulant, anticardiolipin antibody, MPO-ANCA, PR3-ANCA and anti-GBM antibody were all negative. A peripheral blood smear revealed spherical red blood cells ( Figure 1B) . Red blood cell eosin-5maleimide (EMA) binding capacity test results were positive. Furthermore, her mother had a history of spherocytosis. Therefore, hereditary spherocytosis (HS) was diagnosed. With conservative treatment and dehydration prevention, RBC, Hb and Ht improved to 464 Â 10 4 /ll, 14.2 g/dl and 42.1%, respectively. BRAO has not recurred to date.
Discussion
HS (known as Minkowski-Chauffard disease) is part of a heterogeneous group of diseases affecting red blood cells. 1 The clinical spectrum of HS ranges from asymptomatic, with incidental diagnosis by laboratory analysis or other indication, to severe forms requiring transfusions in early childhood. 1 Although the typical characteristic features in HS are anaemia, jaundice, splenomegaly and family history, 1 our patient only had a family history. The EMA test, introduced in 2000, is based on the fluorescent dye eosin-5-maleimide binding to erythrocytes; binding is decreased in patients with HS compared with healthy people. 1 The sensitivity of the EMA test is 90-95%, while its specificity is 95-99%. 1 We considered that our patient could have HS because of the spherical red blood cells in the peripheral blood smear and the positive EMA test.
Retinal artery occlusion (RAO) is an extremely rare diagnosis in the paediatric population. Likewise, retinal arterial obstruction in patients younger than 30 has been estimated at less than 1 in 50 000 outpatients. 2 Multiple mechanisms can cause arterial occlusion in the retina; frequent aetiologies include hypercoagulable states, hyperhomocysteinemia, vasculitis, emboli from cardiac valvular disease and other risk factors such as smoking, use of oral contraceptives and vasospasms sometimes occurring in patients with a history of migraine. 2 Patients with RAO present with acute painless loss of vision of a varying degree depending on the absence or presence of a cilioretinal artery and the duration of blood flow cessation. 3 Although there are no previous reports of RAO caused by HS, several cases of polycythemia vera, a slow growing blood cancer, presenting with RAO by hyperviscosity have been previously reported. 4, 5 RAO in our patient was also postulated to be due to hyperviscosity. The dehydration induced by drinking could have caused an additive effect. This is the first case highlighting the fact that vascular occlusion in the eye can be a presenting feature of HS. Clinicians should be aware that vascular occlusions such as BRAOs could occur in patients with HS. 
